RETINA Journal Podcasts

182 - EFFECTIVENESS AND SAFETY OF BIOSIMILAR ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR FOR RETINAL DISEASES

181 - INHERITED RETINAL DISEASE MANAGEMENT IN THE UNITED STATES

180 - COMPARING REFRACTIVE OUTCOMES OF SECONDARY LENS SURGERY BETWEEN OPHTHALMOLOGY SUBSPECIALTIES IN PATIENTS WITH GOOD FINAL VISION

179 - CILIARY NEUROTROPHIC FACTOR THERAPY FOR MACULAR TELANGIECTASIA TYPE 2

178 - TO DRAIN OR NOT TO DRAIN? THE MANCHESTER BUCKLE STUDY

177 - RETINAL BLOOD VELOCITY AFTER INTRAVITREAL INJECTION FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH OPTICAL COHERENCE TOMOGRAPHY USING SPECKLE ANALYSIS

176 - SURGICAL MANAGEMENT AND OUTCOMES OF LARGE HIGH MYOPIC MACULAR HOLES

175 - INFLUENCE OF THE BASELINE MORPHOLOGIC STAGE ON POSTOPERATIVE VISUAL ACUITY AND METAMORPHOPSIA OUTCOMES IN FOVEA-OFF RHEGMATOGENOUS RETINAL DETACHMENT

174 - THE RISK OF RETINAL BREAKS OR DETACHMENT IN FELLOW EYE WITH LATTICE DEGENERATION AFTER PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT

173 - ASSOCIATION BETWEEN IRIS MANIPULATION DURING PHACOVITRECTOMY FOR RETINAL DETACHMENT REPAIR AND PROLIFERATIVE VITREORETINOPATHY

172 - CAN AQUEOUS PROTEOMICS PREDICT THE RECURRENCE OF RHEGMATOGENOUS RETINAL DETACHMENT?

171 - SLEEP DEPRIVATION AND EPIRETINAL MEMBRANE RISK Machine Learning Findings from a Nation-wide Survey

170 - THE "SCOLEX" SIGN A Distinct Hyperreflective Foci on the Wall of Serous Pigment Epithelial Detachments in Central Serous Chorioretinopathy - Micron Report Number Seven

169 - Photobiomodulation in Dry Age-Related Macular Degeneration: Promising Signal, Familiar Questions

168 - LARGE-SIZED HUMAN AMNIOTIC MEMBRANE PATCHING-ASSISTED VITRECTOMY FOR THE MANAGEMENT OF POSTOPERATIVE PROLIFERATIVE VITREORETINOPATHY IN COMPLEX RHEGMATOGENOUS RETINAL DETACHMENTS

167 - IMPACT OF SLEEP APNEA ON RETINAL VEIN OCCLUSION IN INDIVIDUALS 55 AND YOUNGER A Retrospective Cohort Study

166 - COMPARING THE ABILITY OF GENETIC TESTING TO PROVIDE A DEFINITIVE DIAGNOSIS IN PATIENTS WITH PERIPHERAL AND MACULAR INHERITED RETINAL DISEASE

165 - ANTIBIOTIC PROPHYLAXIS FOR PREVENTING ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTIONS

164 - EXPANDED FIELD OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY BIOMARKERS ASSOCIATED WITH FUTURE CARDIOVASCULAR DISEASE AND MORTALITY IN PATIENTS WITH DIABETIC RETINOPATHY

163 - ASSOCIATION OF PATIENT AGE WITH RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS FOR TREATMENT OF DIABETIC MACULAR EDEMA

162 - BASAL LAMINAR DEPOSITS AND PSEUDODRUSEN Rethinking Their Role in Age-Related Macular Degeneration Progression

161 - EFFICACY AND SAFETY OF SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE IN MIXED ETIOLOGY NONINFECTIOUS CYSTOID MACULAR EDEMA

160 - PROGNOSTIC FACTORS FOR DEVELOPMENT OF GLIOSIS AFTER INTERNAL LIMITED MEMBRANE FLAP FOR IDIOPATHIC MACULAR HOLES

159 - TYPE 4 MACULAR NEOVASCULARIZATION A New Member of the Optical Coherence Tomography Classification of Neovascularization Age-Related Macular Degeneration

158 - PARS PLANA VITRECTOMY-SUPRACHOROIDAL VISCOPEXY FOR RHEGMATOGENOUS RETINAL DETACHMENT REPAIR

157 - MORPHOMETRIC CHANGES IN MACULAR NEOVASCULARIZATION ARCHITECTURE AFTER FARICIMAB TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

156 - NOVEL METHOD OF DETECTION OF BIREFRINGENT OCULAR AMYLOIDOSIS DEPOSITS USING MONOCHROMATIC WAVELENGTHS OF SCANNING LASER OPHTHALMOSCOPY

155 - IMPACT OF GLP-1 RECEPTOR AGONISTS FOR TYPE 2 DIABETES MELLITUS ON THE DEVELOPMENT AND PROGRESSION OF AGE-RELATED MACULAR DEGENERATION

154 - IMPACT OF THE DEXAMETHASONE IMPLANT ON SLOWING DIABETIC RETINOPATHY PROGRESSION Post Hoc Analysis of the MEAD Study

153 - FEASIBILITY OF THE BIONIKO 3D-PRINTED EYE MODEL AS A TRAINING TOOL FOR INTERNAL LIMITING MEMBRANE PEELING

152 - RETINAL DISPLACEMENT AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR Scleral Buckling versus Pars Plana Vitrectomy (The BEVERLEY Study)

151 - IMPACT OF FARICIMAB VERSUS AFLIBERCEPT ON EPIRETINAL MEMBRANE FORMATION OVER 2 YEARS IN PATIENTS WITH DIABETIC MACULAR EDEMA IN THE PHASE 3 YOSEMITE AND RHINE TRIALS

150 - REAL-WORLD EFFICACY OF INTRAVITREAL METHOTREXATE FOR MANAGING PROLIFERATIVE VITREORETINOPATHY IN RECURRENT RHEGMATOGENOUS RETINAL DETACHMENT

149 - PRERETINAL HYPERREFLECTIVE DOTS A Novel Optical Coherence Tomography Sign Associated With the Development of Epiretinal Membrane After Vitrectomy for Rhegmatogenous Retinal Detachment

148 - ATROPHY GROWTH RATES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION COMPARED WITH FELLOW EYES WITH DRY AGE-RELATED MACULAR DEGENERATION

147 - SIMPLE OBSERVATION AS A MANAGEMENT OPTION FOR EARLY-STAGE COATS DISEASE

146 - TRAUMATIC MACULAR HOLE IN CHILDREN Characteristics, Management, and Outcomes

145 - INCIDENCE, CHARACTERISTICS, AND OUTCOMES OF MACULAR NEOVASCULARIZATION IN EXTENSIVE MACULAR ATROPHY WITH PSEUDODRUSEN-LIKE APPEARANCE

144 - DELAYED-ONSET RECURRENT RETINAL DETACHMENT MORE THAN ONE YEAR AFTER PNEUMATIC RETINOPEXY, SCLERAL BUCKLE, OR VITRECTOMY FOR PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT REPAIR Incidence, Characteristics, and Outcomes

143 - THE EFFECT OF STEROIDS IN THE TREATMENT OF OCULAR HYPOTONY ASSOCIATED WITH PROLIFERATIVE VITREORETINOPATHY

142 - TARGETED INTERVENTIONS LEAD TO QUALITY IMPROVEMENT IN YEAR 2 OF AN ARTIFICIAL INTELLIGENCE-BASED DIABETIC RETINOPATHY DETECTION PROGRAM IN NORTHERN CALIFORNIA

141 - PROGRESSION, TREATMENT, AND OUTCOMES OF RETINAL VASCULAR DISEASES IN PREGNANCY

140 - EVALUATION OF HAND TREMOR SUPPRESSION USING A PASSIVE SURGICAL SUPPORT ROBOT IN SIMULATED RETINAL VASCULAR CANNULATION

139 - VISUAL OUTCOMES AND ADHERENCE CHALLENGES IN PROLIFERATIVE DIABETIC RETINOPATHY ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY IN THE CLINICAL PRACTICE SETTING

138 - VITREOUS SENSING VITRECTOMY

137 - COMBINED INTRAVITREAL AFLIBERCEPT AND ANTI-INFLAMMATORY ORAL SUPPLEMENTATION IN THE TREATMENT OF DIABETIC MACULAR EDEMA Two-Year Randomized Controlled Trial Results

136 - PATHOGENESIS OF ECTOPIC INNER FOVEAL LAYERS AND ITS IMPACT ON VISUAL RECOVERY AFTER EPIRETINAL MEMBRANE PEELING

135 - DELAYED RHEGMATOGENOUS RETINAL DETACHMENT AFTER MACULAR SURGERY

134 - A PRACTICAL AND SIMPLIFIED METHOD FOR STRUCTURE–FUNCTION ANALYSIS IN PATIENTS WITH GLAUCOMA AND RETINAL DISEASE

133 - THERAPEUTIC REFRACTIVE VITRECTOMY FOR THE MANAGEMENT OF VITREOUS FLOATERS AND OPACITIES ASSESSED BY THE STANDARDIZED AND KINETIC ANATOMICAL AND FUNCTIONAL TESTING OF VITREOUS FLOATERS AND OPACITIES